A record rights offering, IPO revival and a quiet M&A market.
Foreign underwriting bolsters US bank profits, while convertibles help issuers deal with volatile credit conditions.
Activist abandons proxy fight with biotech firm in return.
Biggest deal this week was the one that was cancelled.
Gerdau pays 53 percent premium for shares in Ameristeel it doesn't already own.
Is your company saving cash? ARS still a pain in the backside for CFOs Health-care reform verdict? People are cattle
in Deal Talk by 
